CEFEPIME Side Effects

6992671-0 | Abdominal Pain, Dialysis, Infusion Related Reaction, Renal Failure Acute, Tubulointerstitial Nephritis
on Sep 16, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with osteomyelitis and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dialysis (What is dialysis?), infusion related reaction, renal failure acute, tubulointerstitial nephritis. Cefepime dosage: Iv. Patient was hospitalized.

6959355-6 | Hypoxia, Mental Status Changes, Status Epilepticus
Patient was taking Cefepime (View Usage). Patient had the following side effects: hypoxia, mental status changes, status epilepticus on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 144.8 lb, was diagnosed with pneumonia (What is pneumonia?) and. Cefepime dosage: .

6936959-8 | Clostridium Difficile Colitis
Adverse event was reported on Nov 16, 2009 by a Female patient taking Cefepime (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, After Cefepime was administered, patient had the following side effects: clostridium difficile colitis. During the same period patient was treated with XIGRIS (View Xigris Review and Xigris Label ).

6924334-1 | Dialysis, Renal Failure Acute
on Aug 11, 2010 Male patient from UNITED STATES , weighting 95.46 lb, was diagnosed with condition aggravated, cystic fibrosis, pseudomonas infection and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), renal failure acute. Cefepime dosage: 2000 Mg Q8h Iv. During the same period patient was treated with GENTAMICIN (135-175 Mg Q8h Iv) (View Gentamicin Review and Gentamicin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.


6914461-7 | Confusional State, Dyskinesia, Dysphagia, Neurotoxicity
on Aug 05, 2010 Female patient from UNITED STATES , 63 years of age, weighting 180.8 lb, was treated with Cefepime (View Usage). Patient had the following side effects: confusional state, dyskinesia, dysphagia, neurotoxicity. Cefepime dosage: . Patient was hospitalized.

6828621-7 | Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Delirium, Status Epilepticus
Patient was taking Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: blood creatinine increased, creatinine renal clearance decreased, delirium, status epilepticus on Jun 19, 2010 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with sepsis (What is sepsis?) and. Cefepime dosage: 2 G Every 12 Hours, Iv. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ).

6809299-5 | Status Epilepticus
Adverse event was reported on Jun 21, 2010 by a Female patient taking Cefepime (View Usage) (Dosage: ) was diagnosed with osteomyelitis and. Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: status epilepticus. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), IPRATROPIUM + SALBUTAMOL (View Ipratropium + Salbutamol Review and Ipratropium + Salbutamol Label ), OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ). Patient was hospitalized.

6794765-1 | Status Epilepticus
on Jun 14, 2010 Female patient from UNITED STATES , 79 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Cefepime (View Usage). Patient had the following side effects: status epilepticus. Cefepime dosage: . During the same period patient was treated with TOBRAMYCIN SULFATE (View Tobramycin Sulfate Review and Tobramycin Sulfate Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6763870-8 | Agitation, Somnolence, Status Epilepticus, Unresponsive To Stimuli
on May 24, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with osteomyelitis and was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: agitation, somnolence, status epilepticus, unresponsive to stimuli. Cefepime dosage: 1 G Every 12 Hours, Iv. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), CILASTAZOL (View Cilastazol Review and Cilastazol Label ), OXYCODONE AND ACETAMINOPHEN (View Oxycodone And Acetaminophen Review and Oxycodone And Acetaminophen Label ), ALBUTEROL/IPRATROPIUM INHALER (View Albuterol/ipratropium Inhaler Review and Albuterol/ipratropium Inhaler Label ). Patient was hospitalized.

6700055-5 | Anaemia, Aphasia, Decreased Appetite, Mental Disorder, Pyrexia, Renal Failure, Splenomegaly
Patient was taking Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, aphasia (What is aphasia?), decreased appetite, mental disorder, pyrexia, renal failure, splenomegaly on Apr 22, 2010 from BRAZIL Additional patient health information: Male patient , 78 years of age, was diagnosed with infection (What is infection?) and. Cefepime dosage: Interrupted On 17-apr-2010. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ). Patient was hospitalized.

6699023-1 | Pyrexia
Adverse event was reported on Apr 26, 2010 by a Male patient taking Cefepime (View Usage) (Dosage: 1 Gm Every Day Iv) was diagnosed with pneumonia (What is pneumonia?) and. Location: UNITED STATES , 72 years of age, weighting 239.6 lb, Patient had the following side effects: pyrexia.

6641555-6 | Infection, Infusion Related Reaction
on Mar 17, 2010 Female patient from UNITED STATES , 22 years of age, weighting 124.8 lb, was diagnosed with febrile neutropenia and was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: infection (What is infection?), infusion related reaction. Cefepime dosage: 1 Gram Every 8 Hours Iv. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), DIPHENHYDRINE (View Diphenhydrine Review and Diphenhydrine Label ), GLUTAMINE (View Glutamine Review and Glutamine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6641551-9 | Tachycardia, Tachypnoea
on Mar 17, 2010 Female patient from UNITED STATES , 50 years of age, weighting 169.8 lb, was diagnosed with infection (What is infection?) and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: tachycardia, tachypnoea. Cefepime dosage: 1 Gram Once Iv. During the same period patient was treated with CAPSAICIN (View Capsaicin Review and Capsaicin Label ), DOCUSATE (View Docusate Review and Docusate Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ).

6638599-7 | Confusional State, Diplopia, Dizziness, Hypersomnia, Hypoacusis, Muscle Twitching, Musculoskeletal Pain, Tremor, Urine Output Decreased
Patient was taking Cefepime (View Usage). Patient had the following side effects: confusional state, diplopia, dizziness (What is dizziness?), hypersomnia, hypoacusis, muscle twitching, musculoskeletal pain, tremor, urine output decreased on Mar 16, 2010 from UNITED STATES Additional patient health information: Male patient , 78 years of age, weighting 160.0 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Cefepime dosage: 1gr/ Every 12 Hours Iv. During the same period patient was treated with VANCOMYCIN (1.25gm Every 48 Hours Iv) (View Vancomycin Review and Vancomycin Label ).

6630766-1 | Diarrhoea
Adverse event was reported on Mar 10, 2010 by a Male patient taking Cefepime (View Usage) (Dosage: 2 Gm Other Iv) was diagnosed with infection (What is infection?) and. Location: UNITED STATES , 57 years of age, After Cefepime was administered, patient had the following side effects: diarrhoea. Patient was hospitalized.

6538606-6 | Rash
on Jan 13, 2010 Male patient from UNITED STATES , 72 years of age, weighting 266.8 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Cefepime dosage: 1 Gm Q12 Iv. During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ), ZOFRAN (View Zofran Review and Zofran Label ), LASIX (View Lasix Review and Lasix Label ), AMBIEN (View Ambien Review and Ambien Label ), ATIVAN (View Ativan Review and Ativan Label ), CAPSAIN (View Capsain Review and Capsain Label ), IMODIUM (View Imodium Review and Imodium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

6531688-7 | Arthritis, Mononeuritis, Myositis, Neuropathy Peripheral, Peroneal Nerve Palsy
on Dec 28, 2009 Female patient from UNITED STATES , 51 years of age, was diagnosed with pyrexia, acute promyelocytic leukaemia and was treated with Cefepime (View Usage). Patient had the following side effects: arthritis (What is arthritis?), mononeuritis, myositis (What is myositis?), neuropathy peripheral, peroneal nerve palsy. Cefepime dosage: . During the same period patient was treated with TOBRAMYCIN SULFATE (View Tobramycin Sulfate Review and Tobramycin Sulfate Label ), TRETINOIN (View Tretinoin Review and Tretinoin Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

6523050-8 | Blood Creatinine Increased, Blood Urea Increased, Cerebral Disorder, Cerebral Ventricle Dilatation, Convulsion, Creatinine Renal Clearance Decreased, Depressed Level Of Consciousness, Encephalopathy, Haemodialysis
Patient was taking Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: blood creatinine increased, blood urea increased, cerebral disorder, cerebral ventricle dilatation, convulsion, creatinine renal clearance decreased, depressed level of consciousness, encephalopathy, haemodialysis on Dec 07, 2009 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Cefepime dosage: Intravenous. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6476623-5 | Clostridium Difficile Colitis, Dehydration, Hypokalaemia
Adverse event was reported on Dec 04, 2009 by a Female patient taking Cefepime (View Usage) (Dosage: 2 Gm Bid Iv) was diagnosed with wound infection and. Location: UNITED STATES , weighting 260.0 lb, Patient experienced the following unwanted or unexpected effects: clostridium difficile colitis, dehydration, hypokalaemia. During the same period patient was treated with CIPROFLOXACIN (500 Mg Bid Po) (View Ciprofloxacin Review and Ciprofloxacin Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LORTAB (View Lortab Review and Lortab Label ), IMDUR (View Imdur Review and Imdur Label ), EFFEXOR (View Effexor Review and Effexor Label ), K DUR (View K-dur Review and K-dur Label ). Patient was hospitalized.

6446858-6 | Encephalopathy, Status Epilepticus
on Nov 12, 2009 Female patient from UNITED STATES , 73 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Cefepime (View Usage). Patient had the following side effects: encephalopathy, status epilepticus. Cefepime dosage: Over 5 Days. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ). Patient was hospitalized.

6430093-1 | Encephalopathy, Status Epilepticus
on Nov 02, 2009 Female patient from UNITED STATES , 73 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: encephalopathy, status epilepticus. Cefepime dosage: Over 5 Days. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ). Patient was hospitalized.

6417257-8 | Blood Pressure Decreased, Body Temperature Increased, Dizziness, Dyspnoea, Eyelid Oedema, Rash
Patient was taking Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, body temperature increased, dizziness (What is dizziness?), dyspnoea, eyelid oedema, rash (What is rash?) on Oct 27, 2009 from UNITED STATES Additional patient health information: Female patient , 38 years of age, weighting 202.8 lb, was diagnosed with pseudomonas infection and. Cefepime dosage: 2 Gm Q12 Iv. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), BACTRIM (View Bactrim Review and Bactrim Label ), BONIVA (View Boniva Review and Boniva Label ), CALCIUM (View Calcium Review and Calcium Label ), CLIMARA (View Climara Review and Climara Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6414808-4 | Blood Pressure Diastolic Decreased, Blood Pressure Systolic Increased, Confusional State, Dialysis, Lethargy, Mood Altered, Muscle Spasms, Muscle Twitching
Adverse event was reported on Oct 26, 2009 by a Male patient taking Cefepime (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: UNITED STATES , 45 years of age, Patient had the following side effects: blood pressure diastolic decreased, blood pressure systolic increased, confusional state, dialysis (What is dialysis?), lethargy, mood altered, muscle spasms, muscle twitching. Patient was hospitalized.

6382619-4 | Creatinine Renal Clearance Decreased, Mental Impairment
on Sep 28, 2009 Female patient from UNITED STATES , 79 years of age, was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: creatinine renal clearance decreased, mental impairment. Cefepime dosage: 2q Q12h. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FOSPHENYTOIN (View Fosphenytoin Review and Fosphenytoin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

6379315-6 | Rash Maculo-papular, Wheezing
on Sep 23, 2009 Female patient from UNITED STATES , 87 years of age, was diagnosed with bacteraemia and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular, wheezing. Cefepime dosage: 2gm Iv Q 24 ?. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), INSULIN (View Insulin Review and Insulin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), GLUCERNA (View Glucerna Review and Glucerna Label ). Patient was hospitalized.

6306510-4 | Dermatomyositis, Leukopenia, Thrombocytopenia
Patient was taking Cefepime (View Usage). Patient had the following side effects: dermatomyositis, leukopenia, thrombocytopenia on Aug 11, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 179.0 lb, was diagnosed with cellulitis orbital and. Cefepime dosage: 2 Gm Every 12 Hours Iv. Patient was hospitalized.

6283900-X | Neutrophil Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jul 22, 2009 by a Male patient taking Cefepime (View Usage) (Dosage: 2000mg Q12h Iv) . Location: UNITED STATES , child 11 years of age, weighting 90.39 lb, After Cefepime was administered, patient had the following side effects: neutrophil count decreased, white blood cell count decreased.

6283254-9 | Rash
on Jul 21, 2009 Female patient from UNITED STATES , 74 years of age, weighting 130.1 lb, was diagnosed with infection (What is infection?) and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Cefepime dosage: 2 Gm Once Iv. Patient was hospitalized.

6269373-1 | Dyskinesia, Encephalopathy, Renal Impairment, Sepsis
on Jun 27, 2009 Male patient from JAPAN , 89 years of age, was diagnosed with cholangitis and was treated with Cefepime (View Usage). Patient had the following side effects: dyskinesia, encephalopathy, renal impairment, sepsis (What is sepsis?). Cefepime dosage: 1 G Every 8 Hours, Iv.

6269373-1 | Dyskinesia, Encephalopathy, Renal Impairment, Sepsis
Patient was taking Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: dyskinesia, encephalopathy, renal impairment, sepsis (What is sepsis?) on Jun 27, 2009 from JAPAN Additional patient health information: Male patient , 89 years of age, was diagnosed with cholangitis and. Cefepime dosage: 1 G Every 8 Hours, Iv.

6258072-8 | Antibiotic Level Above Therapeutic, Status Epilepticus
Adverse event was reported on Jun 17, 2009 by a Female patient taking Cefepime (View Usage) (Dosage: 2 G Twice A Day, Iv) was diagnosed with bronchopneumonia and. Location: FRANCE , 81 years of age, Patient experienced the following unwanted or unexpected effects: antibiotic level above therapeutic, status epilepticus. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (2 G 3 Times A Day, Iv) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ).

6258064-9 | Status Epilepticus
on Jun 17, 2009 Male patient from FRANCE , 61 years of age, was treated with Cefepime (View Usage). Patient had the following side effects: status epilepticus. Cefepime dosage: 500 Mg/day, Then 2 G,.

6258062-5 | Confusional State, Encephalopathy, Status Epilepticus
on Jun 17, 2009 Male patient from FRANCE , 77 years of age, was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: confusional state, encephalopathy, status epilepticus. Cefepime dosage: 3g/day,.

6255952-4 | Aphasia, Muscle Twitching, Muscular Weakness, Somnolence
Patient was taking Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), muscle twitching, muscular weakness, somnolence on Jul 02, 2009 from CHINA Additional patient health information: Female patient , 62 years of age, . Cefepime dosage: .

6255951-2 | Delirium
Adverse event was reported on Jul 02, 2009 by a Male patient taking Cefepime (View Usage) (Dosage: 1 G Bid For 3 Days, From The 4th Day, 3 G Per Day For 2 Days) . Location: CHINA , 59 years of age, Patient had the following side effects: delirium.

6253932-6 | Hepatitis Fulminant
on Jun 22, 2009 Female patient from SPAIN , 46 years of age, was diagnosed with infection (What is infection?) and was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: hepatitis fulminant. Cefepime dosage: . During the same period patient was treated with EBASTINE (View Ebastine Review and Ebastine Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ). Patient was hospitalized.

6253765-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Hepatic Steatosis, Hepatotoxicity
on Jun 16, 2009 Female patient from TURKEY , 57 years of age, was diagnosed with bacteraemia, acute myeloid leukaemia, febrile neutropenia and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, hepatic steatosis, hepatotoxicity. Cefepime dosage: 4 G Daily,. During the same period patient was treated with CYTARABINE (100mg/m^2 For 7 Days,) (View Cytarabine Review and Cytarabine Label ), AMIKACIN (1 G Per Day,) (View Amikacin Review and Amikacin Label ), IDARUBICIN (View Idarubicin Review and Idarubicin Label ), AMPHOTERICIN DEOXYCOLATE (View Amphotericin Deoxycolate Review and Amphotericin Deoxycolate Label ).

6252250-X | Bacteraemia, Staphylococcal Infection
Patient was taking Cefepime (View Usage). Patient had the following side effects: bacteraemia, staphylococcal infection (What is staphylococcal infection?) on Jun 15, 2009 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 70 years of age, was diagnosed with bacteraemia, klebsiella infection and. Cefepime dosage: 2 G Every 12 Hours, Iv. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6252248-1 | Bacteraemia, Pyrexia, Therapeutic Response Decreased
Adverse event was reported on Jun 15, 2009 by a Male patient taking Cefepime (View Usage) (Dosage: 2 G Every 12 Hours, Iv) was diagnosed with klebsiella bacteraemia and. Location: KOREA, REPUBLIC OF , 41 years of age, After Cefepime was administered, patient had the following side effects: bacteraemia, pyrexia, therapeutic response decreased. Patient was hospitalized.

6252247-X | Therapeutic Response Delayed
on Jun 15, 2009 Female patient from KOREA, REPUBLIC OF , 45 years of age, was diagnosed with escherichia bacteraemia and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: therapeutic response delayed. Cefepime dosage: 2 G Every 12 Hours, Iv. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6252246-8 | Candidiasis, Culture Positive, Escherichia Infection
on Jun 15, 2009 Male patient from KOREA, REPUBLIC OF , 70 years of age, was diagnosed with bacteraemia, klebsiella infection and was treated with Cefepime (View Usage). Patient had the following side effects: candidiasis, culture positive, escherichia infection. Cefepime dosage: 2 G Every 12 Hours, Iv. Patient was hospitalized.

6242393-9 | Rash
Patient was taking Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: rash (What is rash?) on Jun 22, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 205.0 lb, was diagnosed with breast infection, pseudomonas infection and. Cefepime dosage: 1g Iv Q12h.

6237719-6 | Convulsion, Loss Of Consciousness, Renal Failure, Sepsis
Adverse event was reported on Jun 04, 2009 by a Female patient taking Cefepime (View Usage) (Dosage: (2 G 2x)) was diagnosed with febrile neutropenia and. Location: TURKEY , 55 years of age, Patient experienced the following unwanted or unexpected effects: convulsion, loss of consciousness, renal failure, sepsis (What is sepsis?). During the same period patient was treated with AMIKACIN ((1 G 1x)) (View Amikacin Review and Amikacin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6237718-4 | Cardiac Failure Congestive, Confusional State, Convulsion, No Therapeutic Response, Sepsis
on Jun 04, 2009 Female patient from TURKEY , 75 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Cefepime (View Usage). Patient had the following side effects: cardiac failure congestive, confusional state, convulsion, no therapeutic response, sepsis (What is sepsis?). Cefepime dosage: (2 G 2x). During the same period patient was treated with VANCOMYCIN ((1 G 1x)) (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6235741-7 | Status Epilepticus
on Jun 05, 2009 Female patient from TURKEY , 58 years of age, was diagnosed with pyelonephritis and was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: status epilepticus. Cefepime dosage: 4 G, Unk. During the same period patient was treated with CLARITHROMYCIN (1 Unk, Unk) (View Clarithromycin Review and Clarithromycin Label ).

6235739-9 | Status Epilepticus
Patient was taking Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: status epilepticus on Jun 05, 2009 from TURKEY Additional patient health information: Female patient , 48 years of age, was diagnosed with bronchiectasis and. Cefepime dosage: 2 G, Unk. During the same period patient was treated with CIPROFLOXACIN (400 Mg, Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ).

6235738-7 | Status Epilepticus
Adverse event was reported on Jun 05, 2009 by a Female patient taking Cefepime (View Usage) (Dosage: 2 G, Unk) was diagnosed with febrile neutropenia, cellulitis (What is cellulitis?) and. Location: TURKEY , 33 years of age, Patient had the following side effects: status epilepticus. During the same period patient was treated with CIPROFLOXACIN (400 Mg, Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ), VANCOMYCIN HCL (1 G, Unk) (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

6231901-X | Bacteraemia, Candidiasis, Treatment Failure
on Jun 08, 2009 Male patient from KOREA, REPUBLIC OF , 70 years of age, was diagnosed with febrile neutropenia and was treated with Cefepime (View Usage). After Cefepime was administered, patient had the following side effects: bacteraemia, candidiasis, treatment failure. Cefepime dosage: . During the same period patient was treated with IMIPENEM (View Imipenem Review and Imipenem Label ).

6231900-8 | Treatment Failure
on Jun 08, 2009 Male patient from KOREA, REPUBLIC OF , 41 years of age, was diagnosed with febrile neutropenia and was treated with Cefepime (View Usage). Patient experienced the following unwanted or unexpected effects: treatment failure. Cefepime dosage: . During the same period patient was treated with IMIPENEM (View Imipenem Review and Imipenem Label ).

6231897-0 | Bacteraemia, Treatment Failure
Patient was taking Cefepime (View Usage). Patient had the following side effects: bacteraemia, treatment failure on Jun 08, 2009 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 40 years of age, was diagnosed with febrile neutropenia and. Cefepime dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ).